GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)
INR 79.0
(-2.71%)
INR 79.0
(-2.71%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 147.4 Thousand INR | -98.32% |
| 2022 | 8.78 Million INR | 336.01% |
| 2021 | -3.72 Million INR | -177.71% |
| 2020 | -1.34 Million INR | -123.86% |
| 2019 | 5.62 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.27 Million INR | 388.24% |
| 2023 Q3 | 237.37 Thousand INR | 1.07% |
| 2023 Q1 | 272.91 Thousand INR | -97.11% |
| 2023 Q4 | -443.6 Thousand INR | -286.88% |
| 2023 FY | - INR | -98.32% |
| 2023 Q2 | 234.87 Thousand INR | -13.94% |
| 2022 Q2 | -314.03 Thousand INR | 0.0% |
| 2022 FY | - INR | 336.01% |
| 2022 Q3 | 553.08 Thousand INR | 276.13% |
| 2022 Q4 | 9.43 Million INR | 1605.64% |
| 2021 FY | - INR | -177.71% |
| 2020 FY | - INR | -123.86% |
| 2019 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | 98.544% |
| Biocon Limited | 41.52 Billion INR | 100.0% |
| Blue Jet Healthcare Limited | 2.29 Billion INR | 99.994% |
| Concord Biotech Limited | 4.65 Billion INR | 99.997% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | 99.995% |
| FERMENTA BIOTECH LIMITED | 262.68 Million INR | 99.944% |
| Lyka Labs Limited | 167.58 Million INR | 99.912% |
| Panacea Biotec Limited | -200.6 Million INR | 100.073% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | 105.991% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 349.41 Million INR | 99.958% |
| Supriya Lifescience Limited | 1.83 Billion INR | 99.992% |
| Syngene International Limited | 10.84 Billion INR | 99.999% |
| TAKE Solutions Limited | -1.05 Billion INR | 100.014% |
| Titan Biotech Limited | 360.29 Million INR | 99.959% |
| Transgene Biotek Limited | -4.33 Million INR | 103.397% |
| Vanta Bioscience Limited | 14.19 Million INR | 98.961% |